FRANCE – Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapeutics, and Institut Curie, France’s leading cancer center, have announced a new chapter in their strategic cancer research collaboration. Based…
Read MoreTag: oncology
Royal Philips launches at-home ECG system to reduce clinical trials attrition rates
NETHERLANDS – Royal Philips has unveiled a new at-home ECG system for use in decentralized clinical trials. This new technology is being marketed by the company as a way for…
Read MoreAmerican PE firm buys controlling stake in Avra Labs valued at US$100 million
INDIA –Advent International, a global private equity fund, has announced that it will acquire a controlling stake in Avra Laboratories in a deal valued at US$100 million. Avra, founded in…
Read MoreFDA issues partial hold affecting Gilead’s Magrolimab, an investigational monoclonal antibody
USA – The FDA has temporarily halted trials of Gilead Sciences’ anti-CD47 antibody magrolimab in combination with azacitidine, citing an “apparent imbalance” in investigator-reported suspected unexpected serious adverse reactions (SUSARs)…
Read MoreAster DM Healthcare expands its footprint in India, sets up 6th hospital in Kerala
INDIA – Aster DM Healthcare, one of the largest integrated healthcare providers in the India, is strengthening its foothold in the country by signing a 30-year lease agreement to establish…
Read MoreAstraZeneca forges deal with Scorpion Therapeutics worth US$1.6 billion
USA – AstraZeneca has announced that it will use Scorpion Therapeutics’ discovery platform to develop precision medicines against previously difficult-to-target cancer proteins. According to Susan Galbraith, AstraZeneca’s executive vice president…
Read MoreLilly bags a license worth US$1.5 billion for a batch of metabolic candidates with Regor Therapeutics
USA – Eli Lilly has formed a multi-year collaboration with China-based Regor Therapeutics Group to discover and develop new therapies for metabolic disorders in a deal that will see the…
Read MoreBDR Pharma launches generic Midostaurin for treatment of Leukemia
INDIA – BDR Pharma, one of India’s leading generic pharmaceutical companies, has launched the country’s first generic-midostaurin under the brand name MSTARIN, which is indicated in rare, difficult-to-treat cancers. The…
Read MoreJohnson & Johnson to split into two publicly traded companies
USA – Johnson & Johnson, the world’s largest health-care conglomerate, has announced plans to separate its consumer products business from its pharmaceutical and medical device operations, resulting in the formation…
Read MoreOncology chain HealthCare Global raises stake in Suchirayu to become majority owner
INDIA – HealthCare Global Enterprises Limited (HCG), a cancer-focused healthcare services provider, announce that it has acquired a majority stake in Suchirayu Healthcare Solutions, gaining an additional 60.9 percent in…
Read More